Immutep Ltd. (IMMP)
0.2852
-0.03
(-10.00%)
USD |
NASDAQ |
Sep 18, 09:41
Immutep Market Cap : 42.03M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 46.70M |
| September 16, 2026 | 48.19M |
| September 15, 2026 | 48.68M |
| September 14, 2026 | 48.79M |
| September 11, 2026 | 55.01M |
| September 10, 2026 | 47.91M |
| September 09, 2026 | 52.33M |
| September 08, 2026 | 53.76M |
| September 04, 2026 | 53.78M |
| September 03, 2026 | 53.81M |
| September 02, 2026 | 56.43M |
| September 01, 2026 | 54.70M |
| August 31, 2026 | 53.94M |
| August 28, 2026 | 56.15M |
| August 27, 2026 | 56.12M |
| August 26, 2026 | 56.00M |
| August 25, 2026 | 56.28M |
| August 24, 2026 | 56.89M |
| August 21, 2026 | 56.90M |
| August 20, 2026 | 57.64M |
| August 19, 2026 | 57.96M |
| August 18, 2026 | 58.55M |
| August 17, 2026 | 56.96M |
| August 14, 2026 | 56.00M |
| August 13, 2026 | 59.46M |
| Date | Value |
|---|---|
| August 12, 2026 | 56.46M |
| August 11, 2026 | 57.96M |
| August 10, 2026 | 56.61M |
| August 07, 2026 | 56.86M |
| August 06, 2026 | 55.28M |
| August 05, 2026 | 57.80M |
| August 04, 2026 | 57.99M |
| August 03, 2026 | 56.06M |
| July 31, 2026 | 56.30M |
| July 30, 2026 | 55.97M |
| July 29, 2026 | 56.12M |
| July 28, 2026 | 56.99M |
| July 27, 2026 | 56.49M |
| July 24, 2026 | 56.66M |
| July 23, 2026 | 57.83M |
| July 22, 2026 | 57.31M |
| July 21, 2026 | 58.85M |
| July 20, 2026 | 60.07M |
| July 17, 2026 | 60.39M |
| July 16, 2026 | 64.20M |
| July 15, 2026 | 64.36M |
| July 14, 2026 | 63.78M |
| July 13, 2026 | 66.39M |
| July 10, 2026 | 61.75M |
| July 09, 2026 | 61.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CSL Ltd. | 60.78B |
| Ceryvyn Therapeutics Ltd. | 3.967M |
| Propanc Biopharma, Inc. | 0.5669M |
| Mesoblast Ltd. | 1.932B |
| Actinogen Medical Ltd. | 115.59M |
Market Cap Related Metrics
| PS Ratio | 4.185 |
| PEG Ratio | -0.0138 |
| Price | 0.2852 |
| Earnings Yield | -127.7% |
| PEGY Ratio | -0.0138 |